• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

GRAS Notices

  • Print
  • Share
  • E-mail
-

The inventory of GRAS notices provides information about GRAS notices filed since 1998, when FDA received its first GRAS notice. As of October 17, 2016, the GRAS final rule (81 FR 54960; August 17, 2016) requires a specific format for a GRAS notice. Prior to that date, FDA processed GRAS notices under the framework of the GRAS proposed rule (62 FR 18938; April 17, 1997). Notices received prior to the effective date of the GRAS final rule provide examples for potential notifiers for the types of information that may support a GRAS conclusion. In the inventory, notices follow the requirements for the format and content of a GRAS notice as of the effective date of the GRAS final rule.

The inventory notes what type of response letter the FDA sent in response to the notice. Notifiers often resubmit notices that FDA previously ceased to evaluate at the notifier’s request, and resubmitted notices commonly receive a letter indicating FDA has no questions, after addressing deficiencies. In the inventory, entries for notices that were later resubmitted link to the newer entry in the final column. Newer entries for notices that were resubmitted include a link to the previous submission below the substance name.

Some GRNs that FDA previously ceased to evaluate at the notifier’s request were later resubmitted as a food additive petition. For each of these cases, the GRN detail page links to the food additive petition.

After issuing a response letter, we may issue a subsequent letter as circumstances warrant. The issue dates of any subsequent letters are listed under the column, "Date of add’l correspondence.”

We will update this information approximately monthly. More information about this inventory is available on the GRAS Notice Inventory Introduction page.


Search and display hints:

  • Select the specific GRN number below to view additional details about any GRAS Notice.
  • To sort by a specific field, click on the column header for that field.
  • To browse the records, use the Show All, First/Previous/Next/Last, and Jump To options at the bottom of the data table.
  • To search for a specific substance/term, enter the term in the Search box and select Show Items to display only those records that contain the selected term. (The search results also includes terms not shown on this page, but included in the full record on the detail page.)
  • The search results will return hits of records containing words that include the search term. For example, a search for the color red will return results that include terms such as reduce, ingredient, and cultured. To limit results to only the searched term, place a space before and after the word in the basic search or in the advanced search “this exact phrase” field.
Download GRAS Notices data in Microsoft Excel web format Download data from this searchable database in Excel format. If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.

Choose a field to search. (An asterisk (*) indicates that the field is found on an individual record's detail page and is not shown below.)

Search within these results
Records Found: 1163 Show All Page 14 of 24
GRN No.
(sorted Z-A)
Substance Date of closure FDA's Letter Date of add'l correspondence Resubmitted as GRN No.
  513
Dried biomass of Euglena gracilis containing beta-1,3-glucan from Euglena gracilis Jul 9, 2014 At the notifier's request, FDA ceased to evaluate this notice
  512
High purity Rebaudioside M Oct 24, 2014 FDA has no questions
  511
Citric acid esters of mono- and diglycerides Nov 10, 2014 FDA has no questions
  510
Acid lactase from Aspergillus oryzae expressed in Aspergillus niger Sep 29, 2014 FDA has no questions
  509
Glucose oxidase enzyme preparation derived from Penicillium chrysogenum Nov 6, 2014 FDA has no questions
  508
Salts from dried mineral water (65% NaCl) Sep 24, 2014 At the notifier's request, FDA ceased to evaluate this notice
  507
Amylomaltase enzyme preparation from Bacillus amyloliquefaciens carrying an amylomaltase gene from Thermus thermophiles Sep 11, 2014 FDA has no questions
  506
Sacha inchi oil, a vegetable oil derived from Plukenetia volubilis. Sep 10, 2014 FDA has no questions
  505
Phosphodiesterase I enzyme preparation from Leptographium procerum Aug 12, 2014 FDA has no questions
  504
Milk protein concentrate and milk protein isolate
   (Resubmission of GRN 444)
Nov 21, 2014 FDA has no questions
  503
Tamarind seed polysaccharide Aug 12, 2014 FDA has no questions
  502
Lactobacillus acidophilus La-14 Aug 19, 2014 FDA has no questions
  501
L-theanine (chemically synthesized) Jul 30, 2014 FDA has no questions
  500
Hydroethanolic extract of Caralluma fimbriata Aug 11, 2014 FDA has no questions
  499
Magnesium L-threonate hydrate Sep 3, 2014 FDA has no questions
  498
D-psicose Jun 12, 2014 FDA has no questions
  497
Polyphenols from the fruit of Litchi chinensis Sonn. and from leaves of Camellia sinensis (L.) Sinensis Jun 12, 2014 FDA has no questions; some uses may require a color additive listing
  496
Aqueous extract of Brassica oleracea var. italica Plenck seeds. Jan 11, 2016 FDA has no questions
  495
Galacto-oligosaccharides May 30, 2014 FDA has no questions
  494
Fatty acid ethyl ester from anchovy or menhaden oil, standardized to approximately 50 percent palmitoleic acid Dec 16, 2014 FDA has no questions
  493
High purity steviol glycosides (minimum purity 95%) May 30, 2014 FDA has no questions
  492
Phytosterols and phytosterol esters Jun 24, 2014 FDA has no questions
  491
Rooster combs extract Jun 6, 2014 FDA has no questions
  490
Phospholipase A2 enzyme preparation from Trichoderma reesei Mar 5, 2014 At the notifier's request, FDA ceased to evaluate this notice
  489
Galacto-oligosaccharides May 22, 2014 FDA has no questions
  488
Benzalkonium chloride May 15, 2014 At the notifier's request, FDA ceased to evaluate this notice
  487
Dried citrus pulp Jun 6, 2014 FDA has no questions
  486
Oil from the seeds of Buglossoides arvensis Dec 23, 2014 FDA has no questions
  485
Beta-galactosidase enzyme preparation Apr 15, 2014 FDA has no questions
  484
Galacto-oligosaccharides May 8, 2014 FDA has no questions
  483
Aqueous extract of Emblica officinalis
   (Resubmission of GRN 322)
Apr 17, 2014 FDA has no questions
  482
Beta-glucanase and xylanase enzyme preparation from Disporotrichum dimorphosporum Jul 3, 2014 FDA has no questions
  481
Meso-zeaxanthin Apr 11, 2014 FDA has no questions; some uses may require a color additive listing
  480
Dried aqueous extract derived from white kidney bean (Phaseolus vulgaris)
   (Resubmission of GRN 434)
May 30, 2014 FDA has no questions
  479
Beta-glucanase, cellulase, and xylanase enzyme preparation from Talaromyces emersonii Mar 7, 2014 FDA has no questions
  478
Rice hull fiber Sep 14, 2015 FDA has no questions
  477
Long-chain inulin Mar 4, 2014 FDA has no questions
  476
Asparaginase enzyme preparation produced by genetically modified Bacillus subtilis Feb 3, 2014 FDA has no questions
  475
Citrus fruit extract May 8, 2014 FDA has no questions
  474
Piperine derived from the fruits of Piper nigrum L (black pepper) or P. longum (long pepper) Sep 19, 2013 At the notifier's request, FDA ceased to evaluate this notice
  473
Purified steviol glycosides with rebaudioside X as the principal component Dec 17, 2013 FDA has no questions
  472
Xylanase enzyme preparation derived from Bacillus licheniformis carrying a gene encoding a modified xylanase from B. licheniformis Jan 10, 2014 FDA has no questions
  471
Annatto seed extract May 19, 2014 FDA has no questions; some uses may require a color additive listing
  470
Ethyl cellulose Dec 16, 2013 FDA has no questions
  469
Chlorella protothecoides strain S106 flour with 40-70% lipid (algal flour)
   (Resubmission of GRN 450)
Jun 7, 2013 FDA has no questions; some uses may require a color additive listing
  468
Preparation containing the bacterial monophages, Fo1a and S16, specific to Salmonella Dec 23, 2013 FDA has no questions Apr 6, 2021
Dec 2, 2016
  467
Rebaudioside A purified from the leaves of Stevia rebaudiana (Bertoni) Bertoni Nov 25, 2013 FDA has no questions
  466
Polyglycerol polyricinoleic acid Sep 25, 2013 FDA has no questions
  465
Cow's milk-derived lactoferrin Feb 18, 2014 FDA has no questions
  464
Cow's milk-derived lactoferrin Feb 18, 2014 FDA has no questions

Show All 

jump to page of 24 


GRN No.
(sorted Z-A)
Substance Date of closure FDA's Letter Date of add'l correspondence Resubmitted as GRN No.
-
-